NorthWest Biotherapeutics Inc (NWBO)

[jeffyh]

SOC vs. DCVAX-L vs. SOC+DCVAX-L

This crossover trial game is born to DCVAX-L's win. The number of patients who received DCVAX-L is two third while SOC one third. Only SOC patients were allowed to crossover the oneway bridge to get DCVAX-L. Most of SOC patients already crossed over and have received the vaccine. Finally, PFS already reached PFS end point. Thus, there has been no probability of DCVAX-L's losing the game, I guess